Skip to main content
. 2017 Nov 23;2(5):e000261. doi: 10.1136/esmoopen-2017-000261

Figure 2.

Figure 2

Median duration of treatment in patients in the RECOURSE trial, stratified by adverse event and in the whole population. Pts, patients.